Back to Anti Aging+
Peptide reconstitution calculator
Also known as
Tesamorelin 10mg
Reported half-life
Compound-specific; consult the study literature and analytical documentation
Study schedule
Defined by the approved laboratory protocol
Protocol basis
Use only an approved, compound-specific laboratory protocol
Shipping from Finland
Orders are dispatched with tracked delivery across Europe. Delivery timing is confirmed before an order is placed.
For controlled laboratory research only. Not suitable, approved or designed for human consumption, medical treatment, veterinary applications or diagnostic procedures.
Calculate concentration and syringe units using your approved laboratory protocol.
Research Information
Growth Hormone-Releasing Factor Analog Research Compound
Tesamorelin is a synthetic analog of human growth hormone-releasing factor. FDA labeling describes tesamorelin as a 44-amino-acid sequence of human GRF modified with a hexenoyl moiety attached to the N-terminal tyrosine residue.
Overview
Research involving tesamorelin focuses on GHRH receptor activation, pituitary GH secretion, IGF-1 response, lipolysis-related pathways, and endocrine feedback. Its modified structure has been studied for stability and pharmacokinetic differences compared with native growth hormone-releasing hormone.
Full compound research reference Study context, experimental considerations, protocol references, and limitations
Compound reference
Tesamorelin 10mg research information
A structured laboratory reference based on the product record and published research context. This is not medical advice or a human-use protocol.
Mechanism and research overview
Use the research overview from the catalog together with peer-reviewed literature and compound-specific analytical documentation.
Reported research areas
- Research interest includes cellular stress response, signaling pathways, and longevity-associated research models.
- Research interest includes growth-hormone-axis, IGF-associated, and body-composition research.
- Research interest includes metabolic, incretin, glucose-regulation, and energy-expenditure research.
Experimental considerations
- Validate identity, purity, concentration, and handling requirements before study use.
- Record all preparation, storage, and study parameters in the laboratory protocol.
- This product is not intended for human or veterinary use.
Research protocol reference
- Vial strength
- Use the selected product variant shown above
- Target amount
- Enter only the amount specified by your approved protocol
- Preparation
- Use validated aseptic laboratory procedures
- Calculation
- Open the peptide calculator
No human dose, treatment schedule, injection route, or prescribing advice is provided.
Research status
Sold as a research compound; regulatory status varies by jurisdiction and study context.
Research-use limitations
- Not for human consumption, treatment, diagnosis, or veterinary use.
- Restricted to trained professionals and controlled laboratory settings.
- Institutional approval and jurisdiction-specific compliance may be required.
Storage and handling
Keep sealed and protected from heat and light. Follow the vial label, analytical documentation, and the approved protocol for temperature, reconstitution, stability, and disposal requirements.
Legal status
Research compound only. Not represented as an approved medicine. The purchaser is responsible for lawful procurement, handling, and use.
